These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
229 related articles for article (PubMed ID: 23561329)
1. IL-6 expression predicts treatment response and outcome in squamous cell carcinoma of the esophagus. Chen MF; Chen PT; Lu MS; Lin PY; Chen WC; Lee KD Mol Cancer; 2013 Apr; 12():26. PubMed ID: 23561329 [TBL] [Abstract][Full Text] [Related]
2. The role of DNA methyltransferase 3b in esophageal squamous cell carcinoma. Chen MF; Lu MS; Lin PY; Chen PT; Chen WC; Lee KD Cancer; 2012 Aug; 118(16):4074-89. PubMed ID: 22213175 [TBL] [Abstract][Full Text] [Related]
3. Role of interleukin 1 beta in esophageal squamous cell carcinoma. Chen MF; Lu MS; Chen PT; Chen WC; Lin PY; Lee KD J Mol Med (Berl); 2012 Jan; 90(1):89-100. PubMed ID: 21912958 [TBL] [Abstract][Full Text] [Related]
4. The role of PD-L1 in the radiation response and prognosis for esophageal squamous cell carcinoma related to IL-6 and T-cell immunosuppression. Chen MF; Chen PT; Chen WC; Lu MS; Lin PY; Lee KD Oncotarget; 2016 Feb; 7(7):7913-24. PubMed ID: 26761210 [TBL] [Abstract][Full Text] [Related]
5. 1α,25-Dihydroxyvitamin D3 Inhibits Esophageal Squamous Cell Carcinoma Progression by Reducing IL6 Signaling. Chen PT; Hsieh CC; Wu CT; Yen TC; Lin PY; Chen WC; Chen MF Mol Cancer Ther; 2015 Jun; 14(6):1365-75. PubMed ID: 25824337 [TBL] [Abstract][Full Text] [Related]
6. IL-6-stimulated CD11b+ CD14+ HLA-DR- myeloid-derived suppressor cells, are associated with progression and poor prognosis in squamous cell carcinoma of the esophagus. Chen MF; Kuan FC; Yen TC; Lu MS; Lin PY; Chung YH; Chen WC; Lee KD Oncotarget; 2014 Sep; 5(18):8716-28. PubMed ID: 25238263 [TBL] [Abstract][Full Text] [Related]
7. Epigenetic silencing of HIC1 promotes epithelial-mesenchymal transition and drives progression in esophageal squamous cell carcinoma. Li P; Liu X; Dong ZM; Ling ZQ Oncotarget; 2015 Nov; 6(35):38151-65. PubMed ID: 26510908 [TBL] [Abstract][Full Text] [Related]
8. Role of ALDH1 in the prognosis of esophageal cancer and its relationship with tumor microenvironment. Chen MF; Chen PT; Lu MS; Chen WC Mol Carcinog; 2018 Jan; 57(1):78-88. PubMed ID: 28888039 [TBL] [Abstract][Full Text] [Related]
9. Increased expression of EIF5A2, via hypoxia or gene amplification, contributes to metastasis and angiogenesis of esophageal squamous cell carcinoma. Li Y; Fu L; Li JB; Qin Y; Zeng TT; Zhou J; Zeng ZL; Chen J; Cao TT; Ban X; Qian C; Cai Z; Xie D; Huang P; Guan XY Gastroenterology; 2014 Jun; 146(7):1701-13.e9. PubMed ID: 24561231 [TBL] [Abstract][Full Text] [Related]
10. RACK1 predicts poor prognosis and regulates progression of esophageal squamous cell carcinoma through its epithelial-mesenchymal transition. Wang N; Liu F; Cao F; Jia Y; Wang J; Ma W; Tan B; Wang K; Song Q; Cheng Y Cancer Biol Ther; 2015; 16(4):528-40. PubMed ID: 25719728 [TBL] [Abstract][Full Text] [Related]
11. Cripto-1 acts as a functional marker of cancer stem-like cells and predicts prognosis of the patients in esophageal squamous cell carcinoma. Liu Q; Cui X; Yu X; Bian BS; Qian F; Hu XG; Ji CD; Yang L; Ren Y; Cui W; Zhang X; Zhang P; Wang JM; Cui YH; Bian XW Mol Cancer; 2017 Apr; 16(1):81. PubMed ID: 28431580 [TBL] [Abstract][Full Text] [Related]
12. High MLL2 expression predicts poor prognosis and promotes tumor progression by inducing EMT in esophageal squamous cell carcinoma. Abudureheman A; Ainiwaer J; Hou Z; Niyaz M; Turghun A; Hasim A; Zhang H; Lu X; Sheyhidin I J Cancer Res Clin Oncol; 2018 Jun; 144(6):1025-1035. PubMed ID: 29532228 [TBL] [Abstract][Full Text] [Related]
14. IL-6/STAT3/TWIST inhibition reverses ionizing radiation-induced EMT and radioresistance in esophageal squamous carcinoma. Zang C; Liu X; Li B; He Y; Jing S; He Y; Wu W; Zhang B; Ma S; Dai W; Li S; Peng Z Oncotarget; 2017 Feb; 8(7):11228-11238. PubMed ID: 28061440 [TBL] [Abstract][Full Text] [Related]
15. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Sugimura K; Miyata H; Tanaka K; Hamano R; Takahashi T; Kurokawa Y; Yamasaki M; Nakajima K; Takiguchi S; Mori M; Doki Y Clin Cancer Res; 2012 Sep; 18(18):5144-53. PubMed ID: 22847808 [TBL] [Abstract][Full Text] [Related]
16. Expression of Transcription Factor 21 (TCF21) and Upregulation Its Level Inhibits Invasion and Metastasis in Esophageal Squamous Cell Carcinoma. Chen Y; Zhang C; Chen J; Zhang B; Zhang H; Yang X; Liu J; Wu Q Med Sci Monit; 2018 Jun; 24():4128-4136. PubMed ID: 29909422 [TBL] [Abstract][Full Text] [Related]
17. Wdr66 is a novel marker for risk stratification and involved in epithelial-mesenchymal transition of esophageal squamous cell carcinoma. Wang Q; Ma C; Kemmner W BMC Cancer; 2013 Mar; 13():137. PubMed ID: 23514407 [TBL] [Abstract][Full Text] [Related]
18. Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Gao Y; Yi J; Zhang K; Bai F; Feng B; Wang R; Chu X; Chen L; Song H J Exp Clin Cancer Res; 2017 Nov; 36(1):161. PubMed ID: 29145896 [TBL] [Abstract][Full Text] [Related]
19. [Expression and significance of FoxM1 in esophageal squamous cell carcinoma cells in vitro and in vivo]. Gai L; Mao GX; Liu J; Huang H; Wang X; Yao NH Zhonghua Zhong Liu Za Zhi; 2016 Mar; 38(3):179-84. PubMed ID: 26988822 [TBL] [Abstract][Full Text] [Related]
20. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Yokobori T; Suzuki S; Tanaka N; Inose T; Sohda M; Sano A; Sakai M; Nakajima M; Miyazaki T; Kato H; Kuwano H Cancer Sci; 2013 Jan; 104(1):48-54. PubMed ID: 23013135 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]